NSN 6505-01-650-2681

Part Details | LORAZEPAM INJECTION

6505-01-650-2681

Alternate Parts: NDC17478004001, NDC17478-0040-01, 1389508, 6505NCM152484, 6505-01-650-2681, 01-650-2681, 6505016502681, 016502681

Supply Group (FSG) NSN Assigned NIIN Item Name Code (INC)
65NOV 24, 201501-650-268150832 ( LORAZEPAM INJECTION )
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-650-2681
Part Number Cage Code Manufacturer
NDC17478-0040-0155751AKORN, INC.
138950889875DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL
6505NCM15248464616DEFENSE MEDICAL STANDARDIZATIONBOARD
Technical Data | NSN 6505-01-650-2681
Characteristic Specifications
PRIMARY CONTAINER CONTENT QUANTITY2.0 MILLILITERS
PRIMARY CONTAINER TYPE VIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTHBL2.0 MILLIGRAMS LORAZEPAM
PHARMACEUTICAL VEHICLE TYPEB ANY ACCEPTABLE
ADMINISTRATION INTRAVENOUS AND INTRAMUSCULAR
TOTAL PRIMARY CONTAINER QUANTITY10
SPECIAL FEATURESLORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG /ML; FILL VOLUME: 1 ML; UNIT SIZE: 1 ML; STORE IN REFRIGERATOR 2 TO 8 C (36 TO 46 F); PROTECT FROM LIGHT
PROTECTIVE STORAGE FEATURE REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PART NAME ASSIGNED BY CONTROLLING AGENCYATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE
CONTROLLED SUBSTANCE CLASSIFICATION SCHEDULE IV